Track biotech stocks in clinical trials, FDA approvals, IPOs, and market shifts — in one place.
Start TrackingStatmint is a data-forward healthcare intelligence platform. It consolidates biotech stock insights, IPOs, and drug development milestones into one research-grade source.
Our content is tailored to biotech and pharma — from preclinical pipelines to post-market IPO moves.
We simplify clinical complexity into readable insights and make trends visible through clear visualizations.
Statmint is built to be accessible for students, analysts, and public market professionals alike.
I'm a sophomore at the University of Michigan with a strong interest in the intersection of finance and healthcare. As an Evans Scholar, I launched Statmint to simplify biotech markets for analysts, students, and investors who value clarity in complexity.